Cargando…
Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta‐analysis including data from the OPPTIMUM study
OBJECTIVE: To evaluate the efficacy of vaginal progesterone administration for preventing preterm birth and perinatal morbidity and mortality in asymptomatic women with a singleton gestation and a mid‐trimester sonographic cervical length (CL) ≤ 25 mm. METHODS: This was an updated systematic review...
Autores principales: | Romero, R., Nicolaides, K. H., Conde‐Agudelo, A., O'Brien, J. M., Cetingoz, E., Da Fonseca, E., Creasy, G. W., Hassan, S. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053235/ https://www.ncbi.nlm.nih.gov/pubmed/27444208 http://dx.doi.org/10.1002/uog.15953 |
Ejemplares similares
-
Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta‐analysis of individual patient data
por: Romero, R., et al.
Publicado: (2017) -
Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial
por: Norman, Jane Elizabeth, et al.
Publicado: (2016) -
Trial protocol OPPTIMUM– Does progesterone prophylaxis for the prevention of preterm labour improve outcome?
por: Norman, Jane E, et al.
Publicado: (2012) -
The Feasibility of Cervical Elastography in Predicting Preterm Delivery in Singleton Pregnancy with Short Cervix Following Progesterone Treatment
por: Jung, Yun Ji, et al.
Publicado: (2021) -
Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy
por: Khandelwal, Meena
Publicado: (2012)